Ephedra and bitter orange: cardiovascular risk Both ephedra (banned by the FDA) and bitter orange (its legal cousin) carry cardiovascular risks including elevated heart rate, blood pressure spikes, and in extreme cases, heart attacks and strokes
The cell migration rate was calculated as the ratio of diminishing scratch area to total scratch area (normalized to 0 h)
The medication is typically administered via injection and works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying
Non-medical, supraphysiological use of anabolic steroids can cause insulin resistance, elevate blood glucose levels, and worsen glycaemic controleffects that may oppose the therapeutic aims of Mounjaro in managing type 2 diabetes
Dont miss this this truly informative episode of Be HEALTHistic
Take Control of Your Health Journey Today